NCT04610060 (PowerWalk) is a NA clinical trial of Power walking in Heart Diseases, Ischemic, sponsored by Gulf Medical University.

Who is sponsoring NCT04610060?

NCT04610060 is sponsored by Gulf Medical University.

What drugs are being tested in NCT04610060?

Interventions in NCT04610060: Power walking, Standardised outpatient cardiac rehabilitation.

What condition does NCT04610060 study?

NCT04610060 studies Heart Diseases, Ischemic, Coronary Artery Disease, Coronary Arteriosclerosis, Coronary Syndrome, Coronary Disease.

Is NCT04610060 still recruiting?

NCT04610060 is currently completed. Last updated 18 October 2022.

Last reviewed 2022-10-18 · How we verify

NCT04610060: PowerWalk

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Power Walking in Cardiac Patients Who Underwent Post-coronary Angioplasty

Completed NA Last updated 18 October 2022

What this trial tests

NA trial testing Power walking in Heart Diseases, Ischemic in 24 participants. Completed in 13 September 2020.

Timeline

7 April 2020

Primary endpoint
10 September 2020

13 September 2020

Quick facts

Lead sponsor	Gulf Medical University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	24
Start date	7 April 2020
Primary completion	10 September 2020
Estimated completion	13 September 2020
Sites	1 location across United Arab Emirates

Drugs / interventions tested

Power walking
Standardised outpatient cardiac rehabilitation

Conditions studied

Heart Diseases, Ischemic — all drugs for Heart Diseases, Ischemic →
Coronary Artery Disease — all drugs for Coronary Artery Disease →
Coronary Arteriosclerosis — all drugs for Coronary Arteriosclerosis →
Coronary Syndrome — all drugs for Coronary Syndrome →

Sponsor

Gulf Medical University

Who can join

Adults 18 to 70, any sex, with Heart Diseases, Ischemic or Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The risk and prevalence of cardiovascular disease in United Arab Emirates (UAE) is high with ischemic heart disease ranks first in terms of major cause of mortality. Large number of patients undergoes coronary angioplasty but very few participate in cardiac rehabilitation because its awareness is not widespread in middle east region. The objectives was to find the influence of standardized outpatient cardiac rehabilitation program along with power walking on Heart quality of life (Heart QoL), functional exercise capacity, Left Ventricular Ejection Fraction and metabolic equivalent task (MET's) among patients with post coronary angioplasty. The investigators conducted a randomized clinical trail in out patient physiotherapy department at Thumbay hospitals Dubai, on patients who underwent coronary artery angioplasty. After meeting the inclusion criteria, participants were randomized into standardized outpatient cardiac rehabilitation program along with power walking (intervention group) or standardized outpatient cardiac rehabilitation program (control group). A 4 weeks of 12 outpatient cardiac rehabilitation sessions consisting of 3 sessions per week was provided to both the groups. Intervention group received standardized outpatient cardiac rehabilitation program along with power walking based on targeted heart rate and weekly steps, whereas control group received only standardized outpatient cardiac rehabilitation program based on American College of Sports Medicine (ACSM) Guidelines. The investigators measured Quality Of Life (HRQoL) by HeartQoL questionnaire, Exercise Capacity by 6 min walk test (6MWT), Left ventricle Ejection fraction (LVEF) using Echocardiogram, Metabolic Equivalent Task (MET'S) using Symptom-limited exercise stress test and Average number of steps walked daily using step up smartphone Pedometer App.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Gulf Medical University trials

Trials by the same sponsor.

NCT07468747 — Influence of Implant Insertion Depth on Peri-implant Bone Changes Around Short Implants · NA · not yet recruiting
NCT07468760 — Peri-Implant Hard and Soft Tissue Changes After Immediate Implant Placement With Socket Shield and Immediate Restoration · NA · not yet recruiting
NCT07468773 — Effect of Individually Trained Oral Prophylaxis (iTOP) on Gingival Health in Orthodontic Patients · NA · not yet recruiting
NCT07196826 — Effect of Passive Versus Active Aquatic Therapy Compared With Conventional Physiotherapy for Chronic Low Back Pain · NA · not yet recruiting
NCT07520032 — Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke. · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04610060 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Gulf Medical University
Last refreshed: 18 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04610060.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing